Invesco sees 0.3% lower AUM as of April-end Invesco sees 0.3% lower AUM as of April-end Post ContentivzRead More You might also be interested in reading ImmunityBio stock climbs 10% on FDA RMAT designation. May 12, 2025 In Mainstream ← Previous post Next post →